 |
|
|
| |
A Predictive Tool for Selecting HBeAg-Positive Chronic Hepatitis B Patients Who Have a High Probability of HBV DNA Suppression and HBeAg Seroconversion with Peginterferon Alfa-2a
|
| |
| |
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
H.L.-Y. Chan1, G.V. Papatheodoridis2, D. Messinger3, G. Bakalos4, P. Lampertico5
1Department of Medicine and Therapeutics, Institute of Digestive Disease and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China; 2Department of Gastroenterology, Athens University Medical School, Laiko General Hospital, Athens, Greece; 3IST GmbH, Mannheim, Germany; 4F. Hoffmann-La Roche Ltd, Basel, Switzerland; 5AM & A Migliavacca Center for Liver Disease, 1st Gastroenterology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy
|
| |
|
|
|
|
|
